Top

Thrombosis Journal

Published in:

01-12-2021 | Phlebothrombosis | Review

A review of thromboembolic events in hospitalized COVID-19 patients

Authors: Paul Fontelo, Mrigendra M. Bastola, Zhaonian Zheng, Seo Hyon Baik

Published in: Thrombosis Journal | Issue 1/2021

Abstract

Context

A higher incidence of thromboembolic disorders in COVID-19 has been reported by many clinicians worldwide.

Objective, design and data sources

Selected studies found in PubMed that reported thromboembolic events were included for meta-analysis using weighted fixed and random effects. Data from 19 articles on cohort studies in patients diagnosed with COVID-19 and thromboembolic events, including thrombosis and embolism were included in this review.

Results

The likelihood for developing thromboembolic disorders in hospitalized COVID-19 patients was 0.28 (95% CI 0.21–0.36).

Conclusion

This study further validates the increased risk of VTE in COVID-19 patients when compared to healthy, non-hospitalized people, and hospitalized patients. These findings will be useful to researchers and medical practitioners caring for COVID-19 patients.

Smeeth L, Cook C, Thomas S, Hall A, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367(9516):1075–9. https://doi.org/10.1016/S0140-6736(06)68474-2.CrossRefPubMed

Cui J, Li F, Shi Z. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2018;17(3):181–92.CrossRefPubMedCentral

Li J, You Z, Wang Q, Zhou Z, Qiu Y, Luo R, et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect. 2020;22(2):80–5. https://doi.org/10.1016/j.micinf.2020.02.002.CrossRefPubMedPubMedCentral

Kahn J, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J. 2005;24(11):S223–7. https://doi.org/10.1097/01.inf.0000188166.17324.60.CrossRefPubMed

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. https://doi.org/10.1056/NEJMoa2001017.CrossRefPubMedPubMedCentral

Middle East respiratory syndrome coronavirus (MERS-CoV). Who.int. 2021 [cited 12 March 2021]. Available from: https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov).

Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt G, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–94. https://doi.org/10.1056/NEJMoa030685.CrossRefPubMed

Singh S. Middle East respiratory syndrome virus pathogenesis. Seminars in Respiratory and Critical Care Medicine. 2016;37(04):572–7.CrossRefPubMedPubMedCentral

van den Brand J, Smits S, Haagmans B. Pathogenesis of Middle East respiratory syndrome coronavirus. J Pathol. 2014;235(2):175–84.CrossRefPubMedCentral

10.

Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020;9(1):687–90. https://doi.org/10.1080/22221751.2020.1741327.CrossRefPubMed

11.

ArcGIS Dashboards [Internet]. Gisanddata.maps.arcgis.com. 2021 [cited 29 March 2021]. Available from: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6

12.

Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020;26(6):729–34. https://doi.org/10.1016/j.cmi.2020.03.026.CrossRefPubMedPubMedCentral

13.

Jin S, Jin Y, Xu B, Hong J, Yang X. Prevalence and impact of coagulation dysfunction in COVID-19 in China: a meta-analysis. Thromb Haemost. 2020;120(11):1524–35. https://doi.org/10.1055/s-0040-1714369.CrossRefPubMedPubMedCentral

14.

Barnes B, Adrover J, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford J, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652.CrossRefPubMedPubMedCentral

15.

Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular Endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–8. https://doi.org/10.1056/NEJMoa2015432.CrossRefPubMedPubMedCentral

16.

Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. 2020;30(5):367–9. https://doi.org/10.1038/s41422-020-0327-4.CrossRefPubMedPubMedCentral

17.

Gertz M, Kyle R. Hyperviscosity syndrome. J Intensive Care Med. 1995;10(3):128–41. https://doi.org/10.1177/088506669501000304.CrossRefPubMed

18.

Gupta N, Zhao Y, Evans C. The stimulation of thrombosis by hypoxia. Thromb Res. 2019;181:77–83. https://doi.org/10.1016/j.thromres.2019.07.013.CrossRefPubMed

19.

Oxley T, Mocco J, Majidi S, Kellner C, Shoirah H, Singh I, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60. https://doi.org/10.1056/NEJMc2009787.CrossRefPubMed

20.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRefPubMedPubMedCentral

21.

Stoneham S, Milne K, Nuttall E, Frew G, Sturrock B, Sivaloganathan H, et al. Thrombotic risk in COVID-19: a case series and case–control study. Clin Med. 2020;20(4):e76–81. https://doi.org/10.7861/clinmed.2020-0228.CrossRef

22.

Zhang L, Feng X, Zhang D, Jiang C, Mei H, Wang J, et al. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China. Circulation. 2020;142(2):114–28. https://doi.org/10.1161/CIRCULATIONAHA.120.046702.CrossRefPubMed

23.

Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–4. https://doi.org/10.1111/jth.14830.CrossRefPubMed

24.

Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–50. https://doi.org/10.1016/j.thromres.2020.04.041.CrossRefPubMedPubMedCentral

25.

Demelo-Rodríguez P, Cervilla-Muñoz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M, Toledo-Samaniego N, et al. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020;192:23–6. https://doi.org/10.1016/j.thromres.2020.05.018.CrossRefPubMedPubMedCentral

26.

Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri F. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis. 2020;50(2):281–6. https://doi.org/10.1007/s11239-020-02130-7.CrossRefPubMedPubMedCentral

27.

Middeldorp S, Coppens M, van Haaps T, Foppen M, Vlaar A, Müller M. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Vascular Surg. 2021;9(2):536. https://doi.org/10.1016/j.jvsv.2020.12.004.CrossRef

28.

Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Res. 2020;191:9–14. https://doi.org/10.1016/j.thromres.2020.04.024.CrossRef

29.

Llitjos J, Leclerc M, Chochois C, Monsallier J, Ramakers M, Auvray M, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743–6. https://doi.org/10.1111/jth.14869.CrossRefPubMed

30.

Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–98. https://doi.org/10.1007/s00134-020-06062-x.CrossRefPubMedPubMedCentral

31.

Koleilat I, Galen B, Choinski K, Hatch A, Jones D, Billett H, et al. Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019. J Vasc Surg. 2021;9(1):36–46. https://doi.org/10.1016/j.jvsv.2020.06.012.CrossRefPubMed

32.

Zerwes S, Hernandez Cancino F, Liebetrau D, Gosslau Y, Warm T, Märkl B, et al. Erhöhtes Risiko für tiefe Beinvenenthrombosen bei Intensivpatienten mit CoViD-19-Infektion? – Erste Daten. Chirurg. 2020;91(7):588–94. https://doi.org/10.1007/s00104-020-01222-7.CrossRefPubMed

33.

Thomas W, Varley J, Johnston A, Symington E, Robinson M, Sheares K, et al. Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom. Thromb Res. 2020;191:76–7. https://doi.org/10.1016/j.thromres.2020.04.028.CrossRefPubMedPubMedCentral

34.

Nahum J, Morichau-Beauchant T, Daviaud F, Echegut P, Fichet J, Maillet J, et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19). JAMA Netw Open. 2020;3(5):e2010478. https://doi.org/10.1001/jamanetworkopen.2020.10478.CrossRefPubMedPubMedCentral

35.

Longchamp A, Longchamp J, Manzocchi-Besson S, Whiting L, Haller C, Jeanneret S, et al. Venous thromboembolism in critically ill patients with COVID-19: results of a screening study for deep vein thrombosis. Res Pract Thrombosis Haemostasis. 2020;4(5):842–7. https://doi.org/10.1002/rth2.12376.CrossRef

36.

Gervaise A, Bouzad C, Peroux E, Helissey C. Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department. Eur Radiol. 2020;30(11):6170–7. https://doi.org/10.1007/s00330-020-06977-5.CrossRefPubMedPubMedCentral

37.

Mestre-Gómez B, Lorente-Ramos R, Rogado J, Franco-Moreno A, Obispo B, Salazar-Chiriboga D, et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis. 2020;51(1):40–6.CrossRef

38.

Inciardi R, Adamo M, Lupi L, Cani D, Di Pasquale M, Tomasoni D, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in northern Italy. Eur Heart J. 2020;41(19):1821–9. https://doi.org/10.1093/eurheartj/ehaa388.CrossRefPubMed

39.

Soumagne T, Lascarrou J, Hraiech S, Horlait G, Higny J, d’Hondt A, et al. Factors associated with pulmonary embolism among coronavirus disease 2019 acute respiratory distress syndrome: a multicenter study among 375 patients. Crit Care Explor. 2020;2(7):e0166. https://doi.org/10.1097/CCE.0000000000000166.CrossRefPubMedPubMedCentral

40.

Freeman M, Tukey J. Transformations related to the angular and the square root. Ann Math Stat. 1950;21(4):607–11. https://doi.org/10.1214/aoms/1177729756.CrossRef

41.

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. https://doi.org/10.1016/0197-2456(86)90046-2.CrossRefPubMed

42.

Jackson D. Confidence intervals for the between-study variance in random effects meta-analysis using generalised Cochran heterogeneity statistics. Res Synth Methods. 2013;4(3):220–9. https://doi.org/10.1002/jrsm.1081.CrossRefPubMed

43.

Sedgwick P. Meta-analyses: how to read a funnel plot. BMJ. 2013;346(mar01 2):f1342.CrossRef

44.

Zhang L, Gerson L, Maluf-Filho F. Systematic review and meta-analysis in GI endoscopy: why do we need them? How can we read them? Should we trust them? Gastrointest Endosc. 2018;88(1):139–50. https://doi.org/10.1016/j.gie.2018.03.001.CrossRefPubMed

45.

Heit J, Melton L, Lohse C, Petterson T, Silverstein M, Mohr D, et al. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc. 2001;76(11):1102–10. https://doi.org/10.4065/76.11.1102.CrossRefPubMed

46.

Zhang C, Zhang Z, Mi J, Wang X, Zou Y, Chen X, et al. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis. Medicine. 2019;98(23):e15833. https://doi.org/10.1097/MD.0000000000015833.CrossRefPubMedPubMedCentral

47.

Anderson F, Zayaruzny M, Heit J, Fidan D, Cohen A. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82(9):777–82. https://doi.org/10.1002/ajh.20983.CrossRefPubMed

48.

Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary embolism in patients with COVID-19. Circulation. 2020;142(2):184–6. https://doi.org/10.1161/CIRCULATIONAHA.120.047430.CrossRefPubMed

49.

Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021;5(3):872–88. https://doi.org/10.1182/bloodadvances.2020003763.CrossRefPubMedPubMedCentral

50.

Feature | Thrombosis and COVID-19: FAQs For Current Practice - American College of Cardiology. American College of Cardiology. 2021 [cited 2 April 2021]. Available from: https://www.acc.org/latest-in-cardiology/articles/2020/04/17/14/42/thrombosis-and-coronavirus-disease-2019-covid-19-faqs-for-current-practice

51.

Information on COVID-19 Treatment, Prevention and Research. COVID-19 Treatment Guidelines. 2021 [cited 2 April 2021]. Available from: https://www.covid19treatmentguidelines.nih.gov/antithrombotic-therapy/.

52.

Chandra A, Chakraborty U, Ghosh S, Dasgupta S. Anticoagulation in COVID-19: current concepts and controversies. Postgrad Med J. 2021:postgradmedj-2021-139923. https://doi.org/10.1136/postgradmedj-2021-139923.

Title: A review of thromboembolic events in hospitalized COVID-19 patients
Authors: Paul Fontelo
Mrigendra M. Bastola
Zhaonian Zheng
Seo Hyon Baik
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Phlebothrombosis
COVID-19
Thrombosis
Published in: Thrombosis Journal / Issue 1/2021
Electronic ISSN: 1477-9560
DOI: https://doi.org/10.1186/s12959-021-00298-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Context

Objective, design and data sources

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Prevalence and impact of fibrinolytic dysregulation in patients with acute coronary syndromes

Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity

Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System

Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms

Use of laboratory testing for prediction of postoperative bleeding volume in cardiovascular surgery

Correction to: Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials